Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127180581 | 12718058 | 1 | I | 2010 | 20160830 | 20160906 | 20160906 | EXP | MX-SA-2016SA161590 | AVENTIS | 60.00 | YR | A | M | Y | 95.00000 | KG | 20160906 | CN | MX | MX |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127180581 | 12718058 | 1 | PS | AVAPRO | IRBESARTAN | 1 | Oral | UNK | 20757 | 1 | DF | TABLET | QD | ||||||
127180581 | 12718058 | 2 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | UNK | 20839 | 1 | DF | TABLET | QD | ||||||
127180581 | 12718058 | 3 | C | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | STRENGTH: 32MG | 0 | 1 | DF | TABLET | Q12H |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127180581 | 12718058 | 1 | Hypertension |
127180581 | 12718058 | 2 | Prophylaxis |
127180581 | 12718058 | 3 | Hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127180581 | 12718058 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127180581 | 12718058 | Hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127180581 | 12718058 | 1 | 2010 | 0 | ||
127180581 | 12718058 | 2 | 2010 | 0 | ||
127180581 | 12718058 | 3 | 2010 | 201606 | 0 |